Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
Santamato
Andrea
A
Panza
Francesco
F
Solfrizzi
Vincenzo
V
Frisardi
Vincenza
V
Ranieri
Maurizio
M
Fiore
Piero
P
D001905:Botulinum Toxins / Q000009:adverse effects / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*; D012798:Sialorrhea / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D009465:Neuromuscular Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A